Evidence library
Peer-reviewed studies need a calm translator.
A plain-language research hub for abstracts, study types, clinical trials, and how to read new cancer findings without overreacting to a headline.
How to read a study summary
A research result is a piece of evidence, not a command. The safest summary tells readers where the study sits on the path from an idea to patient care.
A cell study may explain a mechanism. An animal study may show whether an idea is plausible enough to test further. An early human trial may focus on dose and safety. A later trial may compare outcomes against a standard approach. Headlines often blur these stages together; the stage is usually the most important thing on the page.
Look for who was included and who was not. A result may not apply to a different cancer type, stage, biomarker group, age range, prior treatment history, or health condition — and that is usually the first thing to check against your own situation.
- Whether the research was in cells, animals, healthy volunteers, or people with cancer.
- What question the researchers actually asked, and what they did not test.
- How many participants or samples were included, and whether the study had a comparison group.
- Whether the outcome was a lab marker, tumor response, side-effect measure, survival, quality of life, cost, or access.
- What would still need to happen before the finding could change patient care.
Research paths
The site can grow into guided paths for readers who want to follow research more deeply without needing a medical degree.
The goal is not to make every reader into a scientist. It is to help people recognize the difference between a promising signal, a practice-changing trial, a press-release headline, and a question worth bringing to an oncology visit.
- From lab idea to patient trialHow preclinical research, early trials, larger comparisons, and safety monitoring fit together.Open
- How to read an abstractLook for the population, intervention, comparison, outcome, limitations, funding, and whether the result is clinically meaningful.
- What to do with a study you findBring it to your care team, ask whether it applies to your exact cancer, stage, biomarkers, and prior treatments, and avoid changing care alone.
If you send us a study
When someone sends us a paper, an abstract, or a headline, we answer with a structured, source-linked summary rather than a hot take.
That means explaining the study's claim in plain language, saying where it sits on the path from an idea to patient care, stating what it cannot tell you, and linking it to the related topics here. If the paper is behind a paywall we work from the abstract, the official release, or the trial record rather than guessing at what the full text says.
- A link to the source abstract or paper, with a plain-language summary beside it.
- The study's actual results kept separate from commentary, hope, speculation, and press-release language.
- The study type and evidence stage named near the top, not buried at the end.
- Any conflicts, funding, or limitations that appear in the public record.
Related places on Cancer Explained
Sources used for this page
- NCI: Cancer ResearchNCI overview of cancer research areas and programs.
- NCI: About Cancer Clinical ResearchTreatment, prevention, screening, supportive care, and observational study types.
- NCI: What Are Clinical Trials?How clinical trials test ways to prevent, find, treat, or improve life with cancer.
- NCI Clinical Trials SearchOfficial NCI tool for searching cancer clinical trials.